Development of targeted delivery systems for nucleic acid drugs

Journal of Drug Targeting

Volumn 4, Issue 6, 1997, Pages 337-357

  Mahato, Ram I ^a   Takakura, Yoshinobu ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Antisense oligonucleotides; Gene delivery; Liposomes; Pharmacokinetics; Plasmid DNA; Polycation ligand conjugate

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CELL SURFACE RECEPTOR; DRUG CARRIER; LIPOSOME; NUCLEIC ACID;

DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG EFFICACY; DRUG HALF LIFE; DRUG STABILITY; DRUG TARGETING; DRUG TISSUE LEVEL; DRUG TRANSPORT; GENE THERAPY; INTERNALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MEMBRANE TRANSPORT; NONHUMAN; PATHOGENESIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW;

EID: 0030792222     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869709017892     Document Type: Review

References (138)

1. Acsadi, G., Jiao, S., Jani, A., Duke, D., Williams, P., Chong, W., and Wolf, J. (1991) Direct gene transfer and expression into rat heart in vivo, New Biol., 3, 71-81.
2. Ali, M., Lemoine, N. R., and Ring, C. J. (1994) The use of DNA viruses as vectors for gene therapy. Gene Ther., 1, 367-384.
3. Altman, S. (1993) RNA enzyme-directed gene therapy, Proc. Natl. Acad. Sci. USA, 90, 10898-10900.
4. Anderson, R. G. W., Kamen, B. A., Rothberg, K. G., and Lacey, S. W. (1992) Potocytosis: Sequestration and transport of small molecules by caveolae, Science, 255, 410-411.
5. Behr, J., Demeneix, B., Loeffler, J., and Perez-Mutul, J. (1989) Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA, Proc. Nail. Acad. Sci. USA, 86, 6982-6986.
6. Blaese, M. Blankenstein, T., Brenner, M., Cohen-Haguenauer, O., Gansbacher, B., Russell, S., Sorrentino, B., and Velu, T. (1995) Vectors in cancer therapy: how will they deliver? Cancer Gene Ther., 2, 291-297.
7. Bock, L, C., Griffin, L. C., Latham, J. A., Vermaas, E. H., and Toole, J. J. (1992) Selection of single-stranded DNA molecules that bind and inhibit human thrombin, Nature, 255, 564-566.
8. Boado. R. J. (1995) Antisense drug delivery through the blood-brain bamer, Adv. Drug Del. Rev., 15, 73-107.
9. Brigham, K. L., Meyrick, B., Cnristman, B., Magnuson, M. A., King, G., and Berry Jr., L. C. (1989) Rapid communications: in vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle, Am. J. Med. Sci, 298, 278-281.
10. Brockman, S. A. and Murphy, R. F. (1993) Endosomal and lysosomal hydrolases. In: K. L. Audus and T. J. Raub (eds ) Biological Barriers to Protein Delivery, Plenum Press, New York, pp. 51-70.
11. Buchardt, O., Egholm, M., Berg, R. H. and Nielsen, P. E. (1993) Peptide nucleic acids and their potential applications in biotechnology, Trends Biotechnol., 11, 384-386.
12. Budker, V. G., Knorre, D. G. and Vlassov, V. V. (1992) Cell membranes as barriers for antisense constructions, Antisense Res. Dev.,2, 177-184.
13. Canonico, A. E., Conrary, J. T., Meyrick, B. and Brigham, K. L. (1994) Aerosol and intravenous transfection of human α 1-antitrypsin gene to lungs of rabbits, Am. J. Resp. Cell Mol. Biol., 10, 24-29.
14. Carmichael, E. P., Chiou, H. C., Findeis, M. A., Spitalny, G. L. and Merwin, J. R. (1995) Targeted delivery of anti-hepatitis B antisense oligonucleotides. In; S. Akhtar (ed.) Delivery Strategies for Antisense Oligonucleotide Therapies, CRC Press, New York, pp 267-282.
15. Chen, J., Stieles, R. J. and Daichendt, K. A. (1994) Galactosylated histone-mediated gene transfer and expression, Hum. Gene Ther., 5, 429-435.
16. Cheng, P.-W. and Yin, W. (1994) Lectin conjugate-directed gene transfer to airway epithelial cells, Biochem. Biophys. Res. Commun., 205, 826-833.
17. Cho, M. J. and Juliano, R. (1996) Macromolecular virus small-molecule therapeutics: drug discovery, development and clinical considerations, Tibtech, 14, 153-158.
18. Citro, G., Szczylik, C., Ginobbi, P., Zupi, G. and Calabretta, B. (1994) Inhibition of leukaemia cell proliferation by folic acidpolylysine-mediated introduction of c-myc antisense oligode-oxynucleotides into HL-60 cells, Br. J. cancer, 69, 463-467.
19. Cohen, J. S. (1991) Antisense oligonucleotides as antiviral agents, Antiviral Res., 16, 121-133.
20. Cohen, J. S. (1994) Design, biological properties and delivery of antisense oligonucleotides. In: G. Gregoriadis, B. McCormack, and G. Poste (eds.) Targeting of Drugs Vol. 4, Plenum Press, New York, pp. 101-111.
21. Cossum, P. A., Sasmor, H., Dellinger, D., Truong, L., Cummins, L., Owen. S. R., Markham, P. M., Shea, J. P. and Crooke, S. (1993) Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats, J. Pharmacol. Exp. Ther., 261, 1181-1190.
22. Crooke, R, M., Graham, M. J., Crooke, M. E. and Crooke, S. T. (1995) In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides, J. Pharmacol. Exp. Ther, 275, 462-473.
23. Crooke, S. T. (1992) Therapeutic applications of oligonucleotides, Annu. Rev. Pharmacol. Toxicol., 32, 329-376.
24. Crooke, S. T. (1995) Delivery of oligonucleotides and polynucleotides, J. Drug Target., 3, 185-190.
25. Crooke, S. T. and Bennett, C. F. (1996) Progress in antisense oligonucleotide therapeutics, Annu. Rev. Pharmacol. Toxicol., 36, 107-129.
26. Curiel, D. T., Agrawal, S., Wagner. E., Cotten, M. (1991) Adenovirus enhancement of transferrin-polylysine-mediated gene delivery, Proc. Natl. Acad. Sci. USA, 88, 8850-8854.
27. Demidov, V. V., Potaman, V. N., Frank-Kamenetskii. M. D., Egholm, M., Buchard, O., Sonnichesen, S. H. and Nielsen, P. E. (1994) Stability of peptide nucleic acids in human serum and cellular extracts, Biochem. Pharmacol., 48, 1310-1313.
28. Dolnick, B. J. (1991) Antisense agents in cancer research and therapeutics, Cancer Invest., 9, 185-194.
29. Dworetzky, S. I., Lanford, R. E. and Feldherr, C. M. (1988) The effects of variations in the number and sequence of targeting signals on nuclear uptake, J. Cell Biol, 107, 1279-1287.
30. Ehrlich, G., Patinkin, D., Ginzber, D., Zakut, H., Eckstein. F. and Soreq, H. (1994) Use of partially phosphorothioated antisense oligonucleotides for sequence-dependent modulation of heraatopoiesis in culture, Antisense Res. Dev., 4, 173-183.
31. Elkins, D. A. and Rossi, J. J. (1995) Cellular delivery of ribozymes. In: S. Akhtar (ed.) Delivery Strategies for Antisense Oligonucleotide Therapeutics, CRC Press, New York, pp. 17-38.
32. Erbacher, P., Roche, A. C., Monsigny, M. and Midoux, P. (1995) Glycosylated polylysine/DNA complexes: Gene transfer efficiency in relation with the size and the sugar substitution level of glycosylated polylysines and with the plasmid size, Bioconjugate Chem., 6, 401-410.
33. Feigner, P. L., Gadek. T. R., Holm, M., Roman. R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M. and Danielsen, M. (1987) Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure, Proc. Natl. Acad. Sci. USA, 84, 7413-7417.
34. Felgner, J. H., Kumar, R., Sridhar, C. N., Wheeler, C. J., Tsai, Y. J., Border, R., Ramsey, P., Martin, M. and Feigner, P. L. (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations, J. Biol. Chem., 269, 2550-2561.
35. Felgner, P. L., Zaugg, R. H. and Norman, J. A. (1995) Synthetic recombinant DNA delivery for cancer therapeutics, Cancer Gene Ther., 2, 61-65.
36. Ferkol, T., Kaetzel, C S and Davis, P. B. (1993) Gene transfer into respiratory epithelial cells by targeting the polymeric immunolobulin receptor, J. Clin. Invest., 92, 2394-2400.
37. Ferkol, T., Perales, J. C., Eckman, E., Kaetzel, C. S., Hanson, R. W. and Davis, P. B. (1995) Gene transfer into the airway epithelium of animals by targeting the polymeric immunolobulin receptor, J. din. Invest., 95, 493-502.
38. Ferkol, T., Perales, J. C., Mularo, F. and Hansen, R. W. (1996) Receptor-mediated gene transfer into macrophagfes, Proc. Natl. Acad. USA., 93, 101-105.
39. Findeis, M. A., Wu, C. H. and Wu, G. Y. (1994) Ligand-based carrier systems for delivery of DNA to hepatocytes, Methods Enzymol., 247, 341-351.
40. Fujita, T., Takakura, Y., Sezaki, H. and Hashida, M. (I995) Control of disposition characteristics of proteins by direct cationizanon in mice, Pharm. Sci., 1, 371-375.
41. Galbraith, W. M., Hobson, W. C., Giclas, P. C., Schechter, P. J. and Agrawal, S. (1994) Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey, Antisense Res. Develop., 4, 201-206.
42. Gao, X. and Huang, L. (1991) A novel cationic liposome reagent for efficient transfection of mammalian cells, Biochem. Biophys. Res. Commun., 179, 280-285.
43. Gao, X. and Huang, L. (1995) Cationic liposome-mediated gene transfer, Gene Ther., 2, 710-722.
44. Gao, W.-Y., Han, F.-S., Storm, C., Egan, W. and Cheng, Y.-C. (1992) Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology, Mol. Pharmacol., 41, 223-229.
45. Gao, W.-Y., Storm, C., Egan, W. and Cheng, Y.-C. (1993) Cellular pharmacology of phosphorothioate homooligodeoxynucleotides in human cells, Mol. Pharmacol., 43, 45-50.
46. Gewirtz, A. M., Stein, C. A. and Glazer, P. M. (1996) Facilitating oligonucleotide delivery: Helping antisense deliver on its promise, Proc. Natt. Acad. Sci. USA, 93, 3161-3163.
47. Ghosh, M. K., Ghosh, K. and Cohen, J. S. (1993) Phosphorothioate-phosphodiester oligonucieotide copolymers: Assessment for antisense applicauon, Anticancer Drug Design, 8, 15-32.
48. Hanvey, J. C , Peffer, N. J., Bisi, J, E., Thomson, S. A., Cadilla, R., Josey, J. A., Ricca, D. J., Hassman, C. F., Bonham, M. A., Au, K. G., Carter, S. G., Bruckenstein, D. A., Boyd, A. L., Noble, S. A. and Babiss, L. E. (1992) Antisnse and antigene properties of peptide nucleic acids, Science. 258, 1481-1485.
49. Harris, S. E., Agrawal, S., Hu, P., Wagner, E. and Curriel, D. T. (1993) Receptor-mediated gene transfer to airway epithelial cells in primary culture, Am. J. Respir. Cell Mol. Biol., 9, 441-441.
50. Hawley-Nelson, P., Ciccarone, V, Gebeyehu, G., Jessee, J and Felgner, P. L. (1993) Lipofectamine reagent: A new, higher efficiency polycationic liposome transfection reagent, Focus, 15, 73-79.
51. Hickman, M. A., Malone, R. W., Lehmann-Bruinsma, K., Sih, T. R., Knoell, D., Szoka, F. C., Walzern, R., Carlson, D. M. and Powell, J. S. (1994) Gene expression following direct injection of DNA into liver, Hum. Gene Ther., 5, 1477-1483.
52. Huckett, B., Ariatti, M. and Hawtrey, A O (1990) Evidence for targeted gene transfer by receptor-mediated endocytosis: Stable expression following insulin-directed entry of NEO in HepG2 cells, Biochem. Pharmacol., 40. 253-263.
53. Huang, A., Huang, L. and Kennel, S. J. (1980) Monoclonal antibody covalently coupled with fatty acid, J. Biol. Chem, 255, 8015-8018.
54. Imoto, H., Sakurama, Y., Ohkouch, K., Tsumi, R., Takakura, Y., Sezaki, H. and Hashida, M. (1992) Disposition characteristics of macrornotecules in the perfused tissue-isolated tumor preparation, Cancer Res., 52, 4396-4401.
55. Iversen, P. L., Zhu, S., Meyer, A. and Zon, G. (1992) Cellular uptake and subcellular distribution of phosphorothioate otigonucleotides into cultured cells, Antisense Res. Dev., 2, 211-222.
56. Jain, R. K. and Baxter, L. T (1993) Extravasation and interstitial transport in tumors. In: K. L. Audus and T. J. Raub (eds.) Biological Barriers to Protein Delivery, Plenum Press, New York, pp. 441-465.
57. Kakutani, T., Endo, K., Nara, E., Nakazora, S. and Hashida, M, (1992) Effect of chronic administration of phenobarbital on the hepatobiliary transport of phenol red: Assessment by statistical moment analysis, Pharm. Res., 9, 908-914.
58. Kaneda, Y., Iwai, K. and Uchida,T. (1989) Increased expression of DNA cointroduced with nuclear protein in adult rat liver, Science, 243, 375-378.
59. 32P]-labeled phosphodiester ohgonucleotides coupled to a neutral avidin/monoclonal antibody conjugate, Drug Metab. Dispos., 23, 55-59.
60. Kawabata, K., Takakura, Y. and Hashida, M. (1995) The fate of plasmid DNA after intravenous injection in mice: Involvement of scavenger receptors in its hepatic uptake, Pharm. Res., 12, 825-830.
61. Ledley, T. S. and Ledley, F. D. (1994) Multicompartment, numerical model of cellular events in the pharmacokinetics of gene therapies, Hum. Gene Ther., 5, 679-691.
62. Legendre, J. Y. and Szoka, F. C., Jr. (1992) Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with canonic liposomes, Pharm. Res., 9, 1235-1242.
63. Leonetti, J. P. and Leserman, L. D. (1993) Targeted delivery of oligonulceotides. In: S. T. Crooke and B. Lebleu (eds.) Antisense Research and Applications, CRC Press. New York, pp. 493-504.
64. Leventis, R. and Silvius, J. R. (1990) Interactions of mammalian cells with dispersions containing novel metabolizable cationic amphiphiles, Biochim. Biophys. Acta, 1023, 124-132.
65. Litzinger, D. C. and Huang, L. (1992) Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications, Biochim. Biophys. Acta., 1113, 201-227.
66. Lu, K.-M., Fischman, A. J., Jyawook, S. L., Hendricks, K., Tompkins, R. G. and Yarmush, M. L. (1994) Antisense DNA delivery in vivo: Liver targeting by receptor-mediated uptake, J. Nuclear Med., 35, 269-275.
67. Machy, P. and Leserman, L. D. (1983) Small liposomes are better than large liposomes for specific delivery in vitro, Biochim. Biophys. Acta, 730, 313-320.
68. Mahato, R. L, Kawabata, K., Nomura, T., Takakura, Y. and Hashida, M. (1995a) Physicochemical and pharmacokinetic characteristics of plasmid DNA complexed with cationic liposomes, J. Pharm. Sci., 84, 1267-1271.
69. Mahato, R, I., Kawabata, K., Takakura. Y. and Hashida, M. (1995b) In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes, J. Drug Target., 3, 149-157.
70. Mahato, R. I., Takakura, Y. and Hashida, M. (1996) Nonviral vectors for in vivo gene delivery: physicochemical and pharmacokinetic considerations, Crit. Rev. Ther. Drug Carrier Syst. (in press).
71. Mahato, R. I., Takemura, S., Takakura. Y. and Hashida, M. (1996) Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine) in mice in press.
72. Mannino, R. J. and Gould-Fogerite, S. (I988) Liposome mediated gene transfer, Biotechniques, 6, 682-690.
73. Marcus-Sekura, C. J., Woerner, A. M., Shinozuka, K., Zon, G. and Quinnan, Jr., G. V. (1987) Comparative inhibition of chloramphenicul acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphodiester. methylphosphonate and phosphorothioate linkages, Nucleic Acids Res., 15, 5749-5763.
74. McGraw, T. E. and Maxfield, F. R. (1991) Intenalization and sorting of macromolecules: Endocytosis. In. R. L. Juliano (ed.) Targeted Drug Delivery, Springer-Verlag, New York. pp. 11-41.
75. McLachalan, G., Davidson, H., Davidson, D., Dickinson, P., Dorin, J. and Porteous, D. (1994) DOTAP as a vehicle for efficient gene delivery in vitro and in viva, Biochimtca, 11, 19-21.
76. Meijer, D. K. F. (1994) Drug targeting with glycoproteins and other peptide carriers: An overview. In: G. Gregoriadis, B. McCormack, and G. Poste (eds.) Targeting of Drugs 4, Plenum, pp. 1-30.
77. Meyer, K. B., Thompson, M. M, Levy. M. Y., Baron, L. G. and Szoka, Jr., F. C. (1995) Intratracheal gene delivery to the mouse airway: Characterization of plasmid DNA expression and pharmacokinetics, Gene Ther., 2, 450-460.
78. Miller, M., Park, M. K. and Hanover, J. A. (1991) Nuclear pore complex: Structure, function, and regulation, Physiol. Rev., 71, 909-949.
79. Mirabelli, C. K., Bennett, C. F., Andersen, K. and Crooke, S. T. (1991) In vitro and in vivo pharmacologic activities of antisense oligonucleotides, Anticancer Drug Des., 6, 647-661.
80. Miyao, T., Takakura, Y., Akiyam, T., Yoneda, F., Sezaki, H. and Hashida, M. (1995) Stability and pharmacokinetics of oligonucleotides modified at terminal linkages in mice, Antisense Res. Develop., 5, 115-121.
81. Mulligan, J. F., Matteucci, M. D. and Martin, J. C. (1993) Current concepts in antisense drug design, J. Med. Chem., 36, 1923-1937.
82. Nicolau, C. and Cudd, A. (1989) Liposomes as carriers of DNA, Crit. Rev. Ther. Drug Carrier Syst., 6, 239-271.
83. Nishikawa, M., Ohtsubo, Y., Ohno, J., Fujita, T., Koyama, Y., Yamashita, F., Hashida, M. and Sezaki, H. (1992) Pharmacokinetics of receptor-mediated hepatic uptake of gtycosylated albumin in mice, Int. J. Pharm., 85, 75-85.
84. Nomura, T., Yamashita, F., Takakura, Y. and Hashida, M. (1995a) Effect of cationic liposomes on intratumoral behavior of gene medicines after local injection, 54th Annual Meeting of Japanese Cancer Association, p. 695.
85. Nomura, T., Yamashita, F., Takakura, Y. and Hashida, M., (1995b) Pharmacokinetic analysis of various lipid carrier systems after intratumoral injection in tissue-isolated tumors, Proceed. Int. Symp. Control. Rel. Bioact. Mater., 22, 420-421.
86. Oberbauer, R., Schreiner, G. F. and Meyer. T. M. (1995) Renal uptake of an 18 mer phosphorothioate oligonucleotide. Kidney Int., 48, 1226-1236.
87. Parente, R. A., Nadasdi, L., Subbarao, N. K. and Szoka, F. C., Jr. (1990) Association of a pH-sensitive peptide membrane vesicles: role of amino acid sequence, Biochemistry, 29, 8713-8719.
88. Perales, J. C., Ferkol, T., Beegen, H., Ratnoff, O. D. and Hanson, R. W. (1994) Gene transfer in vivo: Sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake, Proc. Natl. Acad. USA., 91, 4086-4090.
89. Peters, R. (1986) Fluorescence microphotolysis to measure nucleocytoplasmic transport and intracellular mobility, Biochim. Biopfiys. Acta, 864, 305-359.
90. Plank, C., Oberhauser, B. Mechtler, K., Koch, C. and Wagner, E. (1994) The influence of endosome-destructive peptides on gene transfer using synthetic virus-like gene transfer systems, J. Biol. Chem., 269, 12918-12924
91. Poste, G. (1986) Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies, Cancer Treat. Rep., 70, 183-199.
92. Quartin, R. S. and Wetmur, J. G. (1989) Effect of ionic strength on the hybrization of oligonucleotides with reduced charge due to meihylphosphonate linkages to unmodified oligodeoxynucleotides containing complementary sequence, Biochemistry. 28, 1040-1047.
93. Rappaport, J., Hanss, B., Kopp, J. B . Copeland, T. D., Bruggeman, L. A. Coftman, T M and Klotman, P. E. (1995) Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapy, Kidney Int., 47, 1462-1469.
94. Renkin, E. M. (1985) Capillary transport of macromolecules: pores and other endothelial pathways, J. Appl. Physiol., 58, 315-325.
95. Roberts, B. (1989) Nuclear location signal-mediated protein transport, Biochim. Biophys. Acta, 1008, 263-280.
96. Rose, J. K., Buonocore, L. and Whitt, M. A. (1991) A new cationic liposome reagent mediating nearly quantitative transfection of animal cells, Biotechniques, 10, 520-525.
97. Rothberg, K. G., Ting, Y, Kolhouse, J. F., Kamen, B. A. and Anderson, R. G. W. (1990) The glycophosphouptd-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway, J. Cell Biol, 110, 637-649
98. 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate, Mol. Pharmacol., 45, 932-943.
99. Sarmiento, U. M., Perez, J. R., Becker, J. M. and Narayanan, R. (1994) In vivo toxicological effects of rel A antisense phosphorothioates in CD-1 mice, Antisense Res. Develop., 4, 99-107.
100. Sawai, K., Miyao, T., Takakura, Y. and Hashida, M. (1995) Renal disposition characteristics of oligonucleoddes modified at terminal linkages in the perfused rat kidney, Antisense Res. Dev., 5, 279-287.
101. Sawai, K., Mahato, R. I., Oka, Y., Takakura, Y. and Hashida, M. (1996) Disposition of oligonucleotides in the isolated perfused rat kidney: Involvement of scavenger receptors in their renal uptake, J, Pharmacol. Exp. Ther. 279, 284-290.
102. Schereir, H. (1994) The new frontier; gene and oligonucleotide therapy, Pharm. Acta. Helv., 68, 145-159.
103. Schlepper-Schäffer, J., Hüllsmann, D., Djovkar, A., Meyer, H. E., Herbenz, L., Kolb, H. and Kolb-Bachofen, V. (1986) Endocytosis via galactose receptors in vivo: Ligand size directs uptake hepatocytes and/or liver macrophages, Exp. Cell Res., 165, 494-506.
104. Schwartz, A. L., Friedovich, S. E., Knowles, B. B. and Lodish, H. F. (1981) Characterization of asialoglycoprotein receptor in a continuous hepatoma cell line, J. Biol. Chem., 256, 8878-8881.
105. Semour, L. W. (1992) Passive tumor targeting of soluble macromolecules and drug conjugates, Crit. Rev. Ther. Drug Carrier Syst., 9, 135-187.
106. Stewart, M. J., Piautz, G. E., Del-Buono, L., Yang, Z. Y., Xu, L., Gao, X., Huang, L., Nabel, E. G. and Nabel, G. J. (1992) Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice, Hum. Gene Ther., 3, 267-275.
107. Stein, C. A. (1992) Antisense oliaonucleoddes-promises and pitfall, Leukemia, 6, 967-974.
108. Stull, R. A. and Szoka, Jr., F. C. (1995) Antigene, ribosozyme and aptamer nucleic acid drugs: Progress and prospects, Pharm Res., 12, 465-483.
109. Takakura, Y., Fujita, T., Furitsu, H., Nishikawa, M., Sezaki, H. and Hashida, M. (1994) Pharmacokinetics of succinylated proteins and dextran sulfate in mice: Implications for hepatic targeting of protein drugs by direct succinylation via scavenger receptors, Int. J. Pharm., 105. 19-29.
110. Takakura, Y., Mahato, R. I., Nishikawa, M. and Hashida, M. (1996a) Control of pharmacokinetic profiles of drug-macromolecule conjugates, Adv. Drug Del. Rev., 19, 377-399.
111. Takakura, Y. and Hashida, M. (1996b) Macromolecular carrier systems for targeted drug delivery: Pharmacokinetic considerations on biodistribution, Pharm. Res., 13, 820-831.
112. Takakura, Y., Mahato, R. I., Yoshida, M., Kanamaru, T. and Hashida, M. (I996c) Uptake characteristics of oligonucleotides in the single-pass rat liver perfusion system, Antisense Nucleic Acid Drug Develop., 6, 179-183.
113. Takemura, S., Nishikawa, M., Takakura, Y. and Hashida, M. (1996) Pharmacokinetic analysis of hepaiocyte-specific targeting of plasmid DNA using galactosylated poIy-L-lysine, Proc Int. Symp. Control. Rel. Bioact. Mater., 23, 901-902.
114. Taxman, D. J., Lee, E. S. and Wojchowski, D. M. (1993) Receptortargeted transfection using stable maleimido-transferrin/thiopoly-L-lysine conjugates. Analyt. Biochem., 213, 97-103.
115. Taylor, A. and Granger, D. N. (1984) Exchange of macromolecules across the microcirculation. In: E. M. Renkin and C. C. Michael (eds.) Handbook of Physiology, Section 2: The Cardiovascular System, American Physiology Society, Bethesda, Maryland, pp. 492-494.
116. Tomlinson, E. (1992) Impact of the new biologies on the medical and pharmaceutical sciences, J. Pkarm. Pharmacol., 44 (suppl.), 147-159.
117. Tonkinson, J. L. and Stein, C. A. (1996) Antisense Oligonucleotides as clinical therapeutic agents. Cancer Invest., 14, 54-65.
118. Turek, J. A., Leamon, C. P. and Low, P. S. (1993) Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells, J. Cell Sci., 106, 423-430.
119. Uchida, T. (1988) Introduction of macromolecules into mammalian cells by cell fusion, Exp. Cell Res., 178, 1-17.
120. Uhlenbeck, O. C. (1993) Using ribozymes to cleave RNase. In: S. T. Crooke and B. Lebleu (eds) Antisense Research and Applications, CRC Press, New York, pp. 83-96.
121. Uhlmann, E, and Peyman, A. (1990) Antisense Oligonucleotides: A new therapeutic principle, Chem. Rev., 90, 543-584.
122. Wagner, E., Zenke, M., Gotten, M., Beug, H., and Bimstiel, M. L. (1990) Transferrin-polycation conjugates as carriers for DNA uptake into cells, Proc. Natl. Acad. Sci. USA., 87, 3410-3414.
123. Wang, C. Y. and Huang, L. (1987) pH-sensitive immunoliposome mediated target cell-specific delivery and controlled expression of a foreign gene in mouse, Proc. Natl. Acad. Sci. USA, 84, 7851-7855.
124. Wang, S., Lee, R. J., Cauchon, G., Gorenstein, D. G., and Low, P. S. (1995) Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol, Proc. Natl. Acad. Sci. USA, 92, 3318-3322.
125. Watts, C. and Marsh, M. (1992) Endocytosis: what goes in and how? J. Cell Sci., 103, 1-8.
126. White, J. M. (1992) Membrane fusion, Science, 258, 917-924.
127. Wilson, J. M., Grossma, M., Wu, C. H., Chowdhury, N. R., Wu, G. Y., and Chowdhury, J. R. (1992) Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesteromia in low density lipoprotein receptor-deficient rabbits, J. Biot. Chem., 267, 963-967.
128. Wolf, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., and Feigner, P. L. (1990) Direct gene transfer into mouse muscle in vivo, Science, 247, 1465-1468.
129. Wu, G. Y. and Wu, C. H. (1988) Receptor-mediated gene delivery and expression tn vivo, J Biol. Chem., 263. 14621-14624.
130. Wu. C. H., Wilson, J. m., and Wu, G. Y. (1989) Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements tn vivo, J. Biol. Chem., 264, 16985-16987.
131. Wu, G. Y, Wilson, J. M., Shalaby, F., Grossman, M., Shafritz, D. A., and Wu, C. H. (1991) Receptor-mediated gene delivery in vivo: partial correlation of genetic analbuminemia in nagase rats, J. Biol. Chem., 266, 14338-14342.
132. Wu, G. Y. and Wu, C. H. (1992) Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides, J. Biol. Chem., 267. 12436-12439.
133. Wu-Pong, S. (1994) Oligonucleotides: opportunities for drug therapy and research, Pharm, Technol., 18, 102-114.
134. Wu-Pong, S., and Byron, P. R, (1996) Airway-to-biophase transfer of inhaled Oligonucleotides, Adv. Drug Del. Rev., 19, 47-71
135. Yoshida, K., Mahato, R. I., Kawabata, K., Takakura, Y., and Hashida, M. (1996) Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system, Pharm. Res., 13, 597-601.
136. Yovandich, J., O'Malley, Jr., B. Sikes, M., and Ledley, F. D. (1995) Gene expression to synovial cells by intraarticular administration of plasmid DNA, Hum. Gene Ther, 6, 603-610.
137. Zabner, J., Fasbender, A. J., Maninger, T., Poellinger, K. A., and Welsh, M. J. (1995) Cellular and molecular barriers to gene transfer by a cationic lipid, J. Biol. Chem., 270, 18997-19007.
138. Zenke, M., Steinlein, P., Wagner, E., Cotten, M., Beug, H., and Birnstiel, M. L. (1990) Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietuc cells, Proc. Natl. Acad. Sci. USA., 87, 3655-3659.